Giancarlo Stanton to Undergo Third Round of PRP Injections

New York Yankees slugger Giancarlo Stanton is set to return to New York for a third round of platelet-rich plasma (PRP) injections in his elbows, as announced by manager Aaron Boone. Stanton's recurring elbow pain has limited his spring training activities, and Boone indicated that the five-time All-Star is unlikely to participate in any exhibition games. This update follows Stanton's February 17th admission that he had not swung a bat in three to four weeks due to pain in both elbows, leading to two prior rounds of PRP injections in New York.
​
Despite his recent struggles with injuries, Stanton remains a pivotal player for the Yankees. Last season, he posted a .233 batting average with 27 home runs and 72 RBIs across 114 games, despite a strained left hamstring that sidelined him for over a month. Stanton's postseason performance was notable as well, with a .273 average, seven home runs, and 16 RBIs. Signed to a record $325 million, 13-year contract with the Marlins in 2015, Stanton was acquired by the Yankees in December 2017 and delivered 38 home runs and 100 RBIs in his first season with New York. Although injuries have plagued his career, Stanton's potential to contribute significantly remains high, and the Yankees are hopeful that the PRP treatments will aid in his recovery and allow him to return to form for the upcoming season.